BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12750838)

  • 1. Pharmacokinetics of BNP7787 and its metabolite mesna in plasma and ascites: a case report.
    Verschraagen M; Boven E; Zegers I; Hausheer FH; Van der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):525-9. PubMed ID: 12750838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Pendyala L; Schwartz G; Smith P; Zdanowicz J; Murphy M; Hausheer F
    Cancer Chemother Pharmacol; 2003 May; 51(5):376-84. PubMed ID: 12682786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
    Verschraagen M; Boven E; Torun E; Hausheer FH; Bast A; van der Vijgh WJ
    Biochem Pharmacol; 2004 Aug; 68(3):493-502. PubMed ID: 15242815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
    Verschraagen M; Zwiers TH; de Koning PE; Welink J; van der Vijgh WJ
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):293-302. PubMed ID: 11334343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatography.
    Shanmugarajah D; Ding D; Huang Q; Chen X; Kochat H; Petluru PN; Ayala PY; Parker AR; Hausheer FH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):857-66. PubMed ID: 19278906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.
    Verschraagen M; Zwiers TH; Torun E; Donker MG; Reinhoud NJ; Van der Vijgh WJ
    J Pharm Sci; 2003 May; 92(5):1040-50. PubMed ID: 12712424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
    Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
    Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.
    Verschraagen M; Boven E; Torun E; Erkelens CA; Hausheer FH; van der Vijgh WJ
    Br J Cancer; 2004 Apr; 90(8):1654-9. PubMed ID: 15083199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.
    Hausheer FH; Shanmugarajah D; Leverett BD; Chen X; Huang Q; Kochat H; Petluru PN; Parker AR
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):941-51. PubMed ID: 19714332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer.
    Masuda N; Negoro S; Hausheer F; Nakagawa K; Matsui K; Kudoh S; Takeda K; Yamamoto N; Yoshimura N; Ohashi Y; Fukuoka M
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):533-42. PubMed ID: 20473611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.
    Boven E; Westerman M; van Groeningen CJ; Verschraagen M; Ruijter R; Zegers I; van der Vijgh WJ; Giaccone G
    Br J Cancer; 2005 May; 92(9):1636-43. PubMed ID: 15841080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of BNP7787 in human renal proximal tubule cells.
    Hausheer FH; Ding D; Shanmugarajah D; Leverett BD; Huang Q; Chen X; Kochat H; Ayala PY; Petluru PN; Parker AR
    J Pharm Sci; 2011 Sep; 100(9):3977-84. PubMed ID: 21344411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion.
    Smith PF; Booker BM; Creaven P; Perez R; Pendyala L
    J Clin Pharmacol; 2003 Dec; 43(12):1324-8. PubMed ID: 14615468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.
    Parker AR; Petluru PN; Wu M; Zhao M; Kochat H; Hausheer FH
    Mol Cancer Ther; 2010 Sep; 9(9):2558-67. PubMed ID: 20807779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
    Hausheer FH; Parker AR; Petluru PN; Jair KW; Chen S; Huang Q; Chen X; Ayala PY; Shanmugarajah D; Kochat H
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):381-91. PubMed ID: 20440617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
    Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
    Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
    Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of mesna and total mesna in kidney tissue by high-performance liquid chromatography with electrochemical detection.
    Verschraagen M; Bosma M; Zwiers TH; Torun E; van der Vijgh WJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):33-42. PubMed ID: 12450522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.